Spilios Manolakopoulos

PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

George Papatheodoridis, George Ν. Dalekos, Vana Sypsa et al. · Journal of Hepatology · 2015 · 518 citations

Hepatitis D, Hepatology, Viral Hepatitis +12

The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B

George Papatheodoridis, Ramazan Idılman, George Ν. Dalekos et al. · Hepatology · 2017 · 287 citations

Outcome of Hepatitis B e Antigen–Negative Chronic Hepatitis B on Long-Term Nucleos(t)ide Analog Therapy Starting With Lamivudine *

George Papatheodoridis, Evangelini Dimou, Konstantinos Dimakopoulos et al. · Hepatology · 2005 · 217 citations

Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study

George Papatheodoridis, Spilios Manolakopoulos, Giota Touloumi et al. · Gut · 2011 · 186 citations

Large Balloon Dilation vs. Mechanical Lithotripsy for the Management of Large Bile Duct Stones: A Prospective Randomized Study

Gerasimos Stefanidis, N. Viazis, Douglas K. Pleskow et al. · The American Journal of Gastroenterology · 2010 · 167 citations